Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. Morimoto K, et al. Among authors: sawada r. Cancer Lett. 2024 Apr 10;587:216692. doi: 10.1016/j.canlet.2024.216692. Epub 2024 Feb 9. Cancer Lett. 2024. PMID: 38342232 Free article.
A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC.
Morimoto K, Sawada R, Yamada T, Azuma K, Ito K, Goto Y, Kimura H, Harada T, Shiotsu S, Tamiya N, Chihara Y, Takeda T, Hiranuma O, Hasegawa I, Morimoto Y, Iwasaku M, Tokuda S, Takayama K. Morimoto K, et al. Among authors: sawada r. JTO Clin Res Rep. 2022 Aug 6;3(9):100388. doi: 10.1016/j.jtocrr.2022.100388. eCollection 2022 Sep. JTO Clin Res Rep. 2022. PMID: 36082280 Free PMC article.
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Morimoto K, Yamada T, Sawada R, Azuma K, Goto Y, Harada T, Shiotsu S, Tamiya N, Chihara Y, Takeda T, Hiranuma O, Hasegawa I, Tanaka S, Yoshimura A, Iwasaku M, Tokuda S, Kim YH, Takayama K. Morimoto K, et al. Among authors: sawada r. Cancer Immunol Immunother. 2023 Jun;72(6):1699-1707. doi: 10.1007/s00262-023-03370-1. Epub 2023 Jan 9. Cancer Immunol Immunother. 2023. PMID: 36617602 Free PMC article.
A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study).
Sawada R, Nishioka N, Kim YH, Kiyomi F, Uchino J, Takayama K. Sawada R, et al. Transl Lung Cancer Res. 2023 Aug 30;12(8):1802-1806. doi: 10.21037/tlcr-23-109. Epub 2023 Aug 14. Transl Lung Cancer Res. 2023. PMID: 37691860 Free PMC article.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Katayama Y, Yamada T, Sawada R, Kawachi H, Morimoto K, Watanabe S, Watanabe K, Takeda T, Chihara Y, Shiotsu S, Hibino M, Harada T, Nishioka N, Iwasaku M, Tokuda S, Takayama K. Katayama Y, et al. Among authors: sawada r. Oncologist. 2024 May 3;29(5):e681-e689. doi: 10.1093/oncolo/oyae001. Oncologist. 2024. PMID: 38241181 Free PMC article.
Oncological emergency: myeloparalysis: role of brachytherapy.
Masui K, Sawada R, Yamaguchi K, Hirose A, Tsubokura T. Masui K, et al. Among authors: sawada r. BMJ Support Palliat Care. 2021 Dec 24:bmjspcare-2021-003468. doi: 10.1136/bmjspcare-2021-003468. Online ahead of print. BMJ Support Palliat Care. 2021. PMID: 34952865 No abstract available.
Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy.
Iwai N, Okuda T, Sawada R, Ohara T, Hattori C, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, Komaki T, Sakagami J, Kagawa K, Dohi O, Yasuda H, Itoh Y. Iwai N, et al. Among authors: sawada r. Case Rep Gastroenterol. 2022 Mar 31;16(1):229-234. doi: 10.1159/000522639. eCollection 2022 Jan-Apr. Case Rep Gastroenterol. 2022. PMID: 35528774 Free PMC article.
344 results